Phase I study of EBV specific CTL generated from third party for treatment of EBV associated lymphoproliferative disorder after allogeneic stem cell transplantatio
Phase 1
Recruiting
- Conditions
- EBV associated lymphoproliferative disorder after allogeneic stem cell transplantation
- Registration Number
- JPRN-UMIN000015634
- Lead Sponsor
- agoya University Graduate School of Medicine, Department of Pediatrics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe or uncontrollable bacterial, fungal,and viral (except EBV) infection 2. Uncontrollable GVHD 3. Uncontrollable heart failure 4. Psychoses 5.History of allergic reaction to albumin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events and graft-versus-host disease
- Secondary Outcome Measures
Name Time Method Monitoring of EBV viral load and EBV specific CTL in peripheral blood Clinical course of EBV infection